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Abstract
Introduction Postoperative infection is a major cause of
morbidity and mortality. We investigated two serum markers for
their ability to identify patients at risk for postoperative infection.
Mannan-binding lectin (MBL) is a central molecule of the innate
immune system and MBL deficiency is known to predispose to
infection. Procalcitonin (PCT) is a sensitive marker for bacterial
infection.
Methods We investigated 162 patients undergoing elective
surgery for cancer of the gastrointestinal tract. Patients were
classified as having no complications (group A), having infection
for unknown reason (group B) or having sepsis after events like
aspiration or anastomotic leakage (group C). Analysis was done
pre- and postoperatively for serum levels of MBL, PCT and C-
reactive-protein. DNA was preoperatively sampled and stored
and later analysed for genetic polymorphisms of MBL.
Results The preoperative serum levels of MBL were significantly
lower in group B patients than in group A patients (1332 ± 466
ng/ml versus 2523 ± 181 ng/ml). PCT measured on day one
post-surgery was significantly higher in group B patients than in
group A (3.33 ± 1.08 ng/ml versus 1.38 ± 0.17 ng/ml). Patients
with an aberrant MBL genotype had a significantly higher risk of
postoperative infections than wild-type carriers (p < 0.05).
Conclusion Preoperative MBL and early postoperative PCT
measurement may help identify patients at risk for postoperative
infection.
Introduction
Infection is a major reason for postoperative morbidity and
mortality. Despite the use of new treatment modalities,
improvements in technology and increased experience, mor-
bidity rates are high and sepsis is the most common reason for
mortality in surgical intensive care units [1]. Infection and sep-
sis in surgical patients occurs for various reasons. Some infec-
tions can be attributed to distinct events leading to an
overwhelming bacterial load that would cause sepsis even in
healthy persons, such as anastomotic leakage and aspiration
(group C in this study). In other patients, however, an initial
source of infection is not apparent, but it still occurs (group B
in this study). Events of this type include bactaeremia of
unknown reason, hospital acquired pneumonia, infection of in-
dwelling catheters and bacterial translocation through the
enteral mucosa. In contrast to the first group, these patients
are exposed to a bacterial load that can normally be counter-
acted by the immune system even in the state of acute-phase
metabolism. A compromised immune response of the host
may predispose to clinically serious courses of infection. Vari-
ous markers, including C-reactive protein (CRP), tumor necro-
sis factor α, IL-1, IL-6 and IL-8, have been studied for their
ability to predict, diagnose and to differentiate infection, sys-
temic inflammatory response syndrome and sepsis [2-4].
CRP = C-reactive protein; ELISA = enzyme-linked immunosorbent assay; IL = interleukin; MBL = mannan-binding lectin; PCR = polymerase chain 
reaction; PCT = procalcitonin; SEM = standard error of the mean.Critical Care    Vol 9 No 5    Siassi et al.
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These markers have in common that they indicate activation of
the immune system after infection has occurred. It is general
surgical knowledge that postoperative infections usually occur
after day 5 postoperatively, although there are no statistical
data on this issue. Therefore, not only preoperative markers
but also indicators in the early postoperative phase would be
of predictive value.
Mannan-binding lectin (MBL) is a central part of the innate
immune system. It belongs to a group of proteins called col-
lectins. Its structure enables multiple binding to repeating oli-
gosaccharide structures typical of bacterial surfaces [5]. After
binding to micro-organisms, MBL activates the MBL-associ-
ated serine protease-2 and thus the lectin pathway of comple-
ment activation [6].
Previous studies have shown an increased susceptibility to
bacterial, viral or fungal infections in patients with decreased
MBL-serum levels [7,8]. A recent study identifed serum MBL
level as an independent risk factor for survival in non-surgical
intensive care unit patients [9]. The MBL concentration in
serum is, in part, determined genetically. Some haplotypes
confer low MBL concentrations or the secretion of non-func-
tional protein. The main variants in exon 1 of the gene encod-
ing MBL 2 are termed B, C and D variants, with A indicating
the wild type. There are also polymorphisms in the 5' regula-
tory region at position -550 (H/L), -221 (X/Y variants) and in a
5' untranslated region at position +4 (P/Q variants). Due to
linkage between polymorphisms, only seven common haplo-
types exist with some leading to low MBL serum levels. Muta-
t i o n s  i n  e x o n  1  ( A / 0  a n d  0 / 0 types) and the AX/AX type
especially lead to low MBL serum levels. Altogether, depend-
ing on the disease studied, up to 25% of a Caucasian popula-
tion may have insufficient MBL serum levels [10].
Procalcitonin (PCT), the prohormone of calcitonin, is normally
produced in the C-cells of the thyroid gland and its concentra-
tion in the plasma of healthy subjects is very low (10–50 pg/
ml) [11]. It is induced by bacterial endotoxin or inflammatory
cytokines and both has a chemoattractant role and affects
nitric oxide production.
PCT is preferentially induced during severe generalised bacte-
rial, parasitic or fungal infections with systemic manifestations
rather than in viral infections or inflammatory reactions of non-
infectious origin [12].
In order to characterise patients with an increased susceptibil-
ity to postoperative sepsis, we studied the levels of MBL and
PCT. To assess the influence of MBL polymorphisms, a geno-
type-analysis was performed. As a reference, a widely used
marker of inflammation, CRP, was measured.
Materials and methods
Patients
We investigated patients undergoing major elective surgery
for malignant disease of the gastrointestinal tract at the
Department of Surgery in the University Hospital Erlangen
(Erlangen, Germany) from January 1, 2000, until December
31, 2002. Demographic data for these patients is given in
Table 1. Exclusion criteria were age below 18 years, pre-exist-
ing infection and emergency surgery. Patients were followed
clinically until hospital discharge and postoperative complica-
tions were recorded according to the criteria of the American
Council of Chest Physicians/Society of Critical Care Medicine
[13]. Complications were termed 'postoperative infection'
when signs of sepsis or systemic inflammatory response syn-
drome occurred with no obvious bacterial contamination or
specific surgical problem (i.e. anastomotic leakage) (group B).
Patients with other septic events were grouped separately
(group C).
Blood samples were taken preoperatively on day 3 for MBL
analysis and on day 1 and 3 postoperatively for PCT and CRP
analysis; serum was stored at -76°C. The study was approved
by the institutional ethics committee of the University of
Erlangen.
Table 1
Patient demographic data
Age (years; mean and range) 62.3 (25–83)
Gender
Female 56
Male 116
Type of surgery
Resection of pancreas 28 (16.3%)
Gastrectomy 29 (16.9)
Esophageal resection 17 (9.9%)
Colorectal resection 98 (57.0%)Available online http://ccforum.com/content/9/5/R483
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Measurement of MBL, PCT and CRP
MBL was measured by ELISA (Statens Serum Institut, Copen-
hagen, Denmark). MBL genotyping was performed using a
real-time PCR assay on a LightCycler™ instrument (Roche
Diagnostics, Mannheim, Germany). In this approach, PCR and
melting temperature (Tm) curve analysis are combined based
on the principle of mutation detection by melting point analysis
with a fluorescence resonance energy transfer hybridisation
probe. The three mutations in exon 1 were detected in one
capillary using a sensor probe covering the three mutations.
Amplification of the variants located upstream of the coding
sequence was performed by single colour detection for the H/
L polymorphism and multiplexing by dual colour probes was
used for simultaneous genotyping of X/Y and P/Q. The details
of sample preparation and primer and probe design have been
described elsewhere [14].
For statistical analysis, two groups were made. Group 1
included the genotypes leading to normal MBL levels; these
are the homozygous wild-type carriers with the exception of
the AX/AX type. Group 2 included all carriers of heterozygous
or homozygous variations in exon 1 (A/O and O/O type) and
the AX/AX type.
Serum PCT levels were determined by a specific and ultrasen-
sitive immunoluminometric assay (Lumitest ProCa-S®,
BRAHMS-Diagnostica, Berlin, Germany), which allowed
measurement of the concentration of procalcitonin in human
serum and plasma in the picogram range (5–5770 pg/ml) for
diagnosis of locally restricted bacterial infections. Two mono-
clonal antibodies that bind PCT (the antigen) at two different
binding sites (the calcitonin and katacalcin segments) were
used. One of these antibodies (polyclonal, sheep) was lumi-
nescence labelled (the tracer), and the other (monoclonal,
mouse) was fixed to the inner walls of the tube (coated tube
system). During the course of incubation, both antibodies
react with PCT molecules in the sample to form a sandwich.
The luminescence signal is measured using a suitable lumi-
nometer and the LUMltest® Basiskit reagents.
CRP-analysis was done by turbidimetry (Olympus, Hamburg,
Germany).
Statistical analysis
All serum levels are displayed as mean ± standard error of the
mean (SEM). The statistical analysis was done using the t-test
after logarithmic transformation of the raw data. CRP values
were compared using the Mann-Whitney test. Correlation
analysis was done using Spearman's rank correlation. All p-val-
ues are considered two-tailed. All tests were done using the
SPSS 11.0 statistics software (SPSS, Munich, Germany).
Results
Of the 172 patients included in the study, complete data for
analysis were available for 162. Of these, 137 had no septic
events (group A), 10 patients suffered from postoperative
infections as defined above (group B) (characteristics are
given in Table 2) and 15 patients had septic complications
based on a defined postoperative event (group C) (Table 3).
The mean preoperative and postoperative MBL serum con-
centrations of all patients were 2462 ± 175 and 2375 ± 160
ng/ml, respectively (p = 0.6). The serum level of PCT rose from
0.24 ± 0.1 preoperative to 1.5 ± 0.17 ng/ml postoperative (p
< 0.05).
The mean preoperative MBL serum level in patients with post-
operative infections (group B) was 1332 ± 466 ng/ml com-
pared to 2523 ± 181 ng/ml in group A patients with no
complications (p < 0.05). In patients who developed sepsis
after a defined event (group C), preoperative MBL was 2047
± 254 ng/ml, which did not differ significantly from group A.
Postoperative MBL levels in group B and group A patients dif-
fered significantly at 1156 ± 393 ng/ml and 2442 ± 166 ng/
ml, respectively (p < 0.05) (Fig. 1; complete data are given in
Table 4).
The mean preoperative PCT level was 1.05 ± 1.0 ng/ml in
patients with (group B) and 0.19 ± 0.1 ng/ml in patients with-
out (group A) postoperative infection (p > 0.05). Postopera-
tively, there was a significant difference in PCT values
between group B (3.33 ± 1.08 ng/ml) and group A (1.38 ±
0.17 ng/ml) (Fig. 2; complete data are given in Table 5).
Mean preoperative CRP was 16.0 ± 2.8 ng/l, 10.4 ± 3.0 ng/l
and 11.1 ± 5.0 ng/ml in groups A, B and C, respectively (p >
0.05). On day 3 post surgery, the CRP values were 149.0 ±
5.9 ng/l, 209.4 ± 35.8 ng/l (p > 0.05) and 240.7 ± 22.3 ng/l
(p < 0.05) in groups A, B and C, respectively. The measure-
Table 2
Postoperative infections (group B)
Infection Number of patients (n = 10)
Catheter sepsis 4
Pneumonia 2
Abdominal abscess 3
Urinary tract infection 1
Table 3
Other septic complications (group C)
Complication Number of patients (n = 15)
Anatomotic leak 13
Aspiration 2Critical Care    Vol 9 No 5    Siassi et al.
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ment on day 1 did not show significant differences between
the three groups.
It was possible to perform a MBL genotype analysis in 59
patients. Patients carrying the A/A type but not the XA/XA type
(group 1, n = 35) had a mean preoperative MBL level of
3097.1 ± 475.1 ng/ml, whereas the mean serum MBL in
patients who were heterozygotic or homozygotic for any
mutation in exon 1 (group 2; A/0 (n = 21) and XA/XA type (n
= 3)) was 1794.0 ± 374.6 ng/ml (p = 0.04). The Spearman
rank correlation coefficient between genotype group and pre-
operative serum MBL was -0.315 (p = 0.02) (Fig. 3). Of the
group 1 and group 2 patients, 2/35 (6%) and 6/24 (25%)
developed postoperative infections (group B), respectively (p
= 0.035)
Discussion
The search for a preoperative molecular marker defining
patients at risk for postoperative infections is of great clinical
interest because these patients may benefit from intensified
monitoring. In this study, we show that low MBL serum levels
and aberrant genotype are associated with a higher rate of
postoperative infections. This correlates with earlier studies
reporting a higher risk for infections in patients with MBL defi-
ciency [7-9]. In contrast, a study in patients with fever of
unknown cause showed no association between MBL defi-
ciency and the course of infection [15]. In comparison to our
study, however, the patient collective was not homogenous,
with only fever as the primary entry criterion; the severity of
sepsis differed substantially between patients, whereas the
patient collective in our study was more homogenous. Also,
this study only dealt with patients already having an infection
and did not provide a 'control group' of patients not suffering
from infection. The differences in the results between the two
studies may, therefore, be due to different study designs and
patient collectives. The risk of postoperative infection corre-
lates with the type of surgery [16], which could cause bias. In
our study, only patients undergoing elective surgery for gas-
trointestinal cancer were included. All patients underwent a
resection of the gastrointestinal tract, causing some spillage of
bacteria. The group was thus homogenous for the surgery-
associated risk of infection.
An important issue in the design of our study was the distinc-
tion of patients who suffered complications leading to a bac-
terial challenge that would overwhelm even a normal immune
system (group C) from patients with infection for unknown rea-
son (group B). Mixing these cases in one group would lead to
bias because immunological parameters may not play a great
role in massive infection as it is encountered in group C
patients.
In our study, serum MBL levels did not show a significant
increase postoperatively. Postoperative MBL levels were also
lower in patients with infections compared to those without.
We could, therefore, not show an 'acute phase' like behaviour,
Figure 1
Comparison of pre- and postoperative serum-MBL in group A, B and C  patients Comparison of pre- and postoperative serum-MBL in group A, B and C 
patients. Preoperative (pre-OP) and postoperative (post-OP) mannan-
binding lectin (MBL) serum levels in patients with no postoperative 
infections (group A), with postoperative infections (group B) and with 
postoperative infections after a defined event (group C). Error bars indi-
cate the standard error of the mean.
Figure 2
Comparison of pre- and postoperative serum-PCT in group A, B and C  patients Comparison of pre- and postoperative serum-PCT in group A, B and C 
patients. Preoperative (pre-OP) and postoperative (post-OP) procalci-
tonin (PCT) serum levels in patients with no postoperative infections 
(group A), with postoperative infections (group B) and with postopera-
tive infections after a defined event (group C). Error bars indicate the 
standard error of the mean.Available online http://ccforum.com/content/9/5/R483
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as proposed in other studies. This may be due to the short
postoperative phase investigated in our study. The previously
described significant increase in postoperative MBL levels
occurred on day 9 after surgery [17]. This late increase was
not covered by our study design. Nevertheless, the compari-
son of procalcitonin and CRP as classic acute phase proteins
and MBL showed a clear difference in their postoperative
behaviour. We thus would not encourage the use of the term
'acute-phase protein' for MBL in the postoperative situation.
The analysis of the different genotypes of MBL showed a cor-
relation between mutant genotypes and lower MBL serum lev-
els as described before. The different genotypes were also
strongly associated with postoperative infections; in our study,
MBL serum levels and MBL genotyping showed similar corre-
lation to infections in the samples that were tested for both.
There are conflicting data on the clinical relevance of MBL
mutations. A study on patients with pneumococcal disease
showed an increased risk only in patients homozygous or func-
tionally homozygous for MBL deficiency [7]. In contrast, a
study on febrile neutropenia in children undergoing chemo-
therapy showed a clinical effect in patients with low MBL
serum levels that was not limited to patients with exon 1 muta-
tions [8]. Because the influence of serum levels on clinical out-
come was the primary end-point in this study, we decided to
group the serotypes according to their influence on MBL
serum concentrations.
It has formerly been described that MBL genotyping is supe-
rior to the measurement of serum levels [18]. In our study, we
show that, in the preoperative situation, measurement of MBL
serum levels is as good a clinical marker as genotyping.
Whereas the measurement of serum levels can easily be done
by ELISA, MBL genotyping requires complex procedures that
are not readily available in the clinical setting. This may facili-
tate future clinical use of MBL measurement.
Because MBL is now available both in a plasma-derived and a
recombinant form, the question arises of whether supplemen-
tation in MBL-deficient individuals could minimise the risk of
infections. The size of our study sample was too small to allow
for multivariate analysis. We could not, therefore, identify MBL
deficiency as an independent risk factor. The therapeutic use
of high dose MBL in subjects with normal MBL levels must still
be considered experimental and this approach should be
addressed by larger studies.
In contrast to MBL, PCT showed no significant association
between its preoperative serum level and the risk of postoper-
ative infection. The trend towards higher preoperative PCT lev-
els in group B patients may indicate pre-existing infection or
systemic inflammatory response prior to surgery and needs
further investigation.
Nevertheless, patients who developed infection had signifi-
cantly higher PCT levels in the early postoperative phase. The
measurement was made on day 1, whereas most infections
occur later in the postoperative period. In contrast, CRP,
which is widely used as a marker for infection, only showed a
significant increase in group C patients on day 3. Because
PCT is a sensitive marker of bacterial infection and systemic
inflammation, this indicates that the actual bacterial load does
Table 4
Preoperative and postoperative serum levels of mannan-binding lectin
Group Preoperative MBL (ng/ml) Postoperative MBL (ng/ml)
All patients 2462 ± 175 2375 ± 160
Group A 2523 ± 181 2442 ± 166
Group B 1332 ± 466 1156 ± 393
Group C 2047 ± 254 2266 ± 389
MBL, mannan-binding lectin.
Table 5
Preoperative and postoperative serum levels of procalcitonin
Group Preoperative PCT (ng/ml) Postoperative PCT (ng/ml)
All patients 0.24 ± 0.1 1.5 ± 0.17
Group A 0.19 ± 0.1 1.4 ± 0.17
Group B 1.05 ± 1.0 3.3 ± 1.08
Group C 0.07 ± 0.04 1.1 ± 0.07
PCT, procalcitonin.Critical Care    Vol 9 No 5    Siassi et al.
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not alone predispose to infection. It may instead show that the
individual immune response plays a greater role. Despite the
fact that preoperative PCT levels failed to predict infection, its
early postoperative measurement (day 1) may help identify
patients at risk for infection later on.
In our view, an immunologic factor that predisposes to infec-
tion can only play a role in an infection that occurs when the
bacterial load is that of the average patient. In overwhelming
infections caused by a massive bacterial load, those factors
will not play a clinically significant role. Our results add new
aspects to other studies that have shown increased suscepti-
bility to infection in MBL-deficient individuals in non-surgical
cases.
Conclusion
Low preoperative MBL serum levels, as well as high PCT lev-
els in the early postoperative phase, correlate with the
occurence of postoperative infections. These markers may
thus be useful for distinguishing patients at risk for infection.
Prospective studies are needed to determine whether such
patients benefit from intensified monitoring or prophylactic
therapy.
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